- Home
- EVOK vs CMND Comparison
EVOK vs CMND Comparison
Compare EVOK & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- CMND
- Stock Information
- Founded
- EVOK 2007
- CMND 2017
- Country
- EVOK United States
- CMND Canada
- Employees
- EVOK N/A
- CMND N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- CMND Biotechnology: Pharmaceutical Preparations
- Sector
- EVOK Health Care
- CMND Health Care
- Exchange
- EVOK Nasdaq
- CMND Nasdaq
- Market Cap
- EVOK 7.7M
- CMND 5.3M
- IPO Year
- EVOK 2013
- CMND N/A
- Fundamental
- Price
- EVOK $3.85
- CMND $0.99
- Analyst Decision
- EVOK
- CMND
- Analyst Count
- EVOK 0
- CMND 0
- Target Price
- EVOK N/A
- CMND N/A
- AVG Volume (30 Days)
- EVOK 7.2M
- CMND 2.5M
- Earning Date
- EVOK 08-12-2025
- CMND 09-15-2025
- Dividend Yield
- EVOK N/A
- CMND N/A
- EPS Growth
- EVOK N/A
- CMND N/A
- EPS
- EVOK N/A
- CMND N/A
- Revenue
- EVOK $11,594,083.00
- CMND N/A
- Revenue This Year
- EVOK $57.82
- CMND N/A
- Revenue Next Year
- EVOK $59.12
- CMND N/A
- P/E Ratio
- EVOK N/A
- CMND N/A
- Revenue Growth
- EVOK 89.89
- CMND N/A
- 52 Week Low
- EVOK $1.94
- CMND $0.80
- 52 Week High
- EVOK $12.32
- CMND $2.18
- Technical
- Relative Strength Index (RSI)
- EVOK 46.17
- CMND 48.96
- Support Level
- EVOK $4.26
- CMND $1.00
- Resistance Level
- EVOK $4.70
- CMND $1.25
- Average True Range (ATR)
- EVOK 0.43
- CMND 0.08
- MACD
- EVOK -0.15
- CMND -0.01
- Stochastic Oscillator
- EVOK 4.80
- CMND 18.24
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.